Skip to content
Home/Companies/Biotech/NetZeroNitrogen

NetZeroNitrogen

Biotech·UK·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns NetZeroNitrogen?

NetZeroNitrogen is currently owned by Revent through Revent Fund I (2021 vintage), since 2023.

Hand-verified · updated 2026-07-03

Revent
Investor
Revent
Revent Fund I · 2021 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Revent Fund I

Other portfolio companies in the same fund.

Farmless
Farmless
Active
BiotechNetherlands· 2023
Magnotherm
Magnotherm
Active
IndustrialsGermany· 2023
Resourcify
Active
SoftwareGermany· 2023
Apiday
Apiday
Active
SaaSFrance· 2022
Granular Energy
Granular Energy
Active
ClimateTechFrance· 2022
Noscendo
Active
MedTechGermany· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track NetZeroNitrogen

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy NetZeroNitrogen?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on NetZeroNitrogen.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue